跳至主要内容
临床试验/IRCT20100524004010N33
IRCT20100524004010N33尚未招募2 期

The effect of Nano-curcumin supplementation on clinical symptoms and signs, length of hospital stays and inflammation level in moderate acute pancreatitis.

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Having desire to participate in the study
  • Age range of 18-75
  • Patients with a clinical diagnosis of moderate acute pancreatitis (specifically, a history of acute abdominal pain associated with a greater than threefold elevation of the serum amylase and/or computed tomographic evidence of acute pancreatitis) presenting within 72 hours of onset of pain.
  • Having the ability to intake soft gels orally

排除标准

  • Pregnancy or breastfeeding
  • History of allergy to Curcumin
  • Acute exacerbation of chronic pancreatitis
  • Taking antioxidant supplements such as vitamin C, vitamin E or omega 3
  • Severe co-morbid illness (liver disease including Cirrhosis and Hepatitis, renal failure (Cl Cr <30))
  • Active gastrointestinal ulcers
  • Taking anticoagulants such as Heparin, Clopidogrel, Dipyridamole, Warfarin and Ticlopidine

研究者

相似试验